These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 188007

  • 1. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF, Lorentz WB, Berger M, Smith EH, Carvajal HF, Travis LB.
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [Abstract] [Full Text] [Related]

  • 2. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I, Baumgarten R, Movig KL, van Laarhoven J, Apperloo AJ, Nolen WA, Heerdink ER, Knoers NV, Egberts AC.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):50-7. PubMed ID: 17466972
    [Abstract] [Full Text] [Related]

  • 3. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C, Galli M, Montagnani M, D'Amore I.
    Quad Sclavo Diagn; 1976 Mar 02; 12(1):15-38. PubMed ID: 190633
    [Abstract] [Full Text] [Related]

  • 4. Antidiuretic and urinary cyclic AMP response of vasopressin in normal rats and in rats with lithium-polyuria.
    Christensen S, Geisler A.
    Acta Pharmacol Toxicol (Copenh); 1977 Mar 02; 40(3):447-54. PubMed ID: 190861
    [Abstract] [Full Text] [Related]

  • 5. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
    Dousa TP, Valtin H.
    J Clin Invest; 1974 Sep 02; 54(3):753-62. PubMed ID: 4368480
    [Abstract] [Full Text] [Related]

  • 6. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW, Jeon US, Kim GH, Park J, Oh YK, Kim YS, Ahn C, Kim S, Kim SY, Lee JS, Han JS.
    Nephrol Dial Transplant; 2004 Oct 02; 19(10):2480-6. PubMed ID: 15280526
    [Abstract] [Full Text] [Related]

  • 7. Renal effects of lithium administration in rats: alterations in water and electrolyte metabolism and the response to vasopressin and cyclic-adenosine monophosphate during prolonged administration.
    Martines-Maldonado M, Stavroulaki-Tsapara A, Tsaparas N, Suki WN, Eknoyan G.
    J Lab Clin Med; 1975 Sep 02; 86(3):445-61. PubMed ID: 168279
    [Abstract] [Full Text] [Related]

  • 8. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM, Haghani M.
    Can J Physiol Pharmacol; 2010 Dec 02; 88(12):1191-201. PubMed ID: 21164566
    [Abstract] [Full Text] [Related]

  • 9. The effect of Ringer solution induced extracellular volume expansion on kidney function.
    Kövér G, Tost H, Darvasi A.
    Acta Physiol Hung; 1989 Dec 02; 74(2):141-60. PubMed ID: 2603731
    [Abstract] [Full Text] [Related]

  • 10. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
    Gill JR, Casper AG.
    J Clin Invest; 1971 Jun 02; 50(6):1231-40. PubMed ID: 4326154
    [Abstract] [Full Text] [Related]

  • 11. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr 02; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy.
    Barbour GL, Straub KD, O'Neal BL, Leatherman JW.
    Arch Intern Med; 1979 Jan 02; 139(1):86-8. PubMed ID: 760689
    [Abstract] [Full Text] [Related]

  • 13. Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
    Valtin H, Coffey AK, O'Sullivan DJ, Homma S, Dousa TP.
    Physiol Bohemoslov; 1990 Jan 02; 39(1):103-11. PubMed ID: 2165265
    [Abstract] [Full Text] [Related]

  • 14. Alterations in renal tubular sodium and water transport in polycystic kidney disease.
    D'Angelo A, Mioni G, Ossi E, Lupo A, Valvo E, Maschio G.
    Clin Nephrol; 1975 Jan 02; 3(3):99-105. PubMed ID: 1139805
    [Abstract] [Full Text] [Related]

  • 15. Urinary excretion of aquaporin-2 in patients with diabetes insipidus.
    Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, Bichet DG, Marumo F.
    N Engl J Med; 1995 Jun 08; 332(23):1540-5. PubMed ID: 7537863
    [Abstract] [Full Text] [Related]

  • 16. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
    Jackson BA, Edwards RM, Valtin H, Dousa TP.
    J Clin Invest; 1980 Jul 08; 66(1):110-22. PubMed ID: 6249843
    [Abstract] [Full Text] [Related]

  • 17. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 Jul 08; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 18. Aggravation of subclinical diabetes insipidus during pregnancy.
    Iwasaki Y, Oiso Y, Kondo K, Takagi S, Takatsuki K, Hasegawa H, Ishikawa K, Fujimura Y, Kazeto S, Tomita A.
    N Engl J Med; 1991 Feb 21; 324(8):522-6. PubMed ID: 1992305
    [Abstract] [Full Text] [Related]

  • 19. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T.
    Acta Endocrinol (Copenh); 1985 Apr 21; 108(4):485-90. PubMed ID: 2986401
    [Abstract] [Full Text] [Related]

  • 20. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
    Kaminsky NI, Broadus AE, Hardman JG, Jones DJ, Ball JH, Sutherland EW, Liddle GW.
    J Clin Invest; 1970 Dec 21; 49(12):2387-95. PubMed ID: 5480862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.